ANCA-asszociált vasculitis: vizsgálatok itt: Ausztria
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleRoll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
- Where
- Innsbruck
- Életkor
- 6 év and over
- People
- 230 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07444567 - 3. fázisTaking peopleROSY-F: Roll-over Study for Participants Who Have Completed a Previous Clinical Study with Benralizumab (Fasenra) and Benefit from Continued Treatment
- Where
- Innsbruck
- People
- 94 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-523307-29-00 · EU 2025-523307-29-00 - 4. fázisTaking peopleDiscontinuation of rituximab compared with rituximab maintenance in ANCA-associated vasculitis – a randomized non-blinded controlled trial (DISRITUX)
- Where
- DO NOT EDIT
- Életkor
- 18 év and over
- People
- 130 worldwide
- Run by
- Region Oestergoetland
See details and how to join2023-508398-10-00 · EU 2023-508398-10-00 - 4. fázisTaking peopleEFFECT OF ONCE VS TWICE DAILY ADMINISTRATION OF CORTICOSTEROIDS ON BLOOD GLUCOSE IN PATIENTS WITH ANCA-VASCULITIS MEASURED BY CONTINUOUS BLOOD GLUCOSE MONITORING - A PILOT STUDY
- Where
- Graz
- Életkor
- 18 év and over
- People
- 10
- Run by
- Medical University Of Graz
See details and how to join2024-516141-39-00 · EU 2024-516141-39-00 - No phaseTaking peopleProspective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Characterizing Eosinophils
- Where
- Innsbruck
- Életkor
- 18 év and over
- People
- 300
- Run by
- Medical University Innsbruck
See details and how to joinNCT04538937